Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.

The Journal of antimicrobial chemotherapy - 1 Sept 2003

Piddock Laura J V, Johnson M M, Webber Mark A

Abstract excerpt

AIM: To determine whether an association exists between ciprofloxacin and faropenem resistance in bacteria including multiply drug-resistant isolates. METHODS: The MICs were determined for 150 fluoroquinolone-resistant bacteria, plus 20 nalidixic acid-resistant strains of Salmonella enterica sero...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteria
Share to Bacterial Infections
Share to beta-Lactams

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ciprofloxacin

Share to Imipenem

Share to Lactams

Share to Nalidixic Acid

Share to Thienamycins

Source

Identifiers

PMID: 12917244
DOI: 10.1093/jac/dkg373

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12917244-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.PMID 12917244Read ↗

Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.Semantic proximity Read ↗

Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates.Semantic proximity Read ↗

Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.Semantic proximity Read ↗

Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization.Semantic proximity Read ↗

Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.Semantic proximity Read ↗

Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms.Semantic proximity Read ↗

Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.Semantic proximity Read ↗

In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzae.Semantic proximity Read ↗

In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.Semantic proximity Read ↗

Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.Semantic proximity Read ↗

In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.